Bayer's Pharmaceutical Sales Beat Market Expectations -- Market Talk

Dow Jones11-12

1016 GMT - Bayer's pharmaceutical sales beat market expectations, Jefferies analysts say in a research note. The German conglomerate posted quarterly sales for the division of 4.51 billion euros, above Jefferies estimated 4.23 billion euros and consensus of 4.46 billion euros, the analysts say. Adjusted Ebitda at 1.10 billion euros missed consensus of 1.19 billion euros, but beat Jefferies estimates of 1.09 billion euros. The company posted strong sales across core assets such as Kerendia and Nubeqa, which beat consensus by 7% and 2%, respectively. However, Xarelto came in 7% below consensus. Full-year sales growth at constant currency guidance for pharmaceuticals was raised to between 0% to 3%, from negative 4% to 0% previously. Jefferies expects flat growth. Shares trade 11.5% lower at 21.60 euros. (nina.kienle@wsj.com)

(END) Dow Jones Newswires

November 12, 2024 05:16 ET (10:16 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2482239776?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-12 18:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482239776","market":"hk","top_or_hot":-1,"title":"Bayer's Pharmaceutical Sales Beat Market Expectations -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1016 GMT - Bayer's pharmaceutical sales beat market expectations, Jefferies analysts say in a research note. The German conglomerate posted quarterly sales for the division of 4.51 billion euros, above Jefferies estimated 4.23 billion euros and consensus of 4.46 billion euros, the analysts say. Adjusted Ebitda at 1.10 billion euros missed consensus of 1.19 billion euros, but beat Jefferies estimates of 1.09 billion euros. The company posted strong sales across core assets such as Kerendia and Nubeqa, which beat consensus by 7% and 2%, respectively. However, Xarelto came in 7% below consensus. Full-year sales growth at constant currency guidance for pharmaceuticals was raised to between 0% to 3%, from negative 4% to 0% previously. Jefferies expects flat growth. Shares trade 11.5% lower at 21.60 euros. (nina.kienle@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 12, 2024 05:16 ET (10:16 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer's Pharmaceutical Sales Beat Market Expectations -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer's Pharmaceutical Sales Beat Market Expectations -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-12 18:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1016 GMT - Bayer's pharmaceutical sales beat market expectations, Jefferies analysts say in a research note. The German conglomerate posted quarterly sales for the division of 4.51 billion euros, ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAYRY","symbol_name":"Bayer A.G.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2482239776","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482239776","pubTimestamp":1731406560,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1016 GMT - Bayer's pharmaceutical sales beat market expectations, Jefferies analysts say in a research note. The German conglomerate posted quarterly sales for the division of 4.51 billion euros, above Jefferies estimated 4.23 billion euros and consensus of 4.46 billion euros, the analysts say. Adjusted Ebitda at 1.10 billion euros missed consensus of 1.19 billion euros, but beat Jefferies estimates of 1.09 billion euros. The company posted strong sales across core assets such as Kerendia and Nubeqa, which beat consensus by 7% and 2%, respectively. However, Xarelto came in 7% below consensus. Full-year sales growth at constant currency guidance for pharmaceuticals was raised to between 0% to 3%, from negative 4% to 0% previously. Jefferies expects flat growth. Shares trade 11.5% lower at 21.60 euros. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BAYRY":"Bayer A.G."},"translate_title":"拜耳医药销售超市场预期--市场谈","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"1016 GMT - Bayer's pharmaceutical sales beat market expectations, Jefferies analysts say in a research note. The German conglomerate posted quarterly sales for the division of 4.51 billion euros, above Jefferies estimated 4.23 billion euros and consensus of 4.46 billion euros, the analysts say. Adjusted Ebitda at 1.10 billion euros missed consensus of 1.19 billion euros, but beat Jefferies estimates of 1.09 billion euros. The company posted strong sales across core assets such as Kerendia and Nubeqa, which beat consensus by 7% and 2%, respectively. However, Xarelto came in 7% below consensus. Full-year sales growth at constant currency guidance for pharmaceuticals was raised to between 0% to 3%, from negative 4% to 0% previously. Jefferies expects flat growth. Shares trade 11.5% lower at 21.60 euros. (nina.kienle@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2024 05:16 ET (10:16 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482239776"}